| 摘要 |
<p>The invention relates to compounds of structural formula (I); or a pharmaceutically acceptable salt, solvate, clathrate, and prodrug thereof, wherein Ra, Rb, and R2are defined herein. These compounds inhibit tubulin polymerization and/or target vasculature and are useful for treating proliferative disorders, such as cancer. Figure: None</p> |
| 申请人 |
SYNTA PHARMACEUTICALS CORP. |
发明人 |
SUN, LIJUN;BORELLA, CHRISTOPHER;LI, HAO;JIANG, JUN;CHEN, SHOUJUN;KOYA, KEIZO;INOUE, TAKAYO;DU, ZHENJIAN;FOLEY, KEVIN;WU, YAMING;ZHANG, MEI;YING, WEIWEN |
